These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30160833)

  • 1. Ocular albinism with infertility and late-onset sensorineural hearing loss.
    Fabian-Jessing BK; Vestergaard EM; Plomp AS; Bergen AA; Dreschler WA; Duno M; Winiarska BS; Neumann L; Gaihede M; Vorum H; Petersen MB
    Am J Med Genet A; 2018 Jul; 176(7):1587-1593. PubMed ID: 30160833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel GPR143 mutations and clinical characteristics in six Chinese families with X-linked ocular albinism.
    Fang S; Guo X; Jia X; Xiao X; Li S; Zhang Q
    Mol Vis; 2008; 14():1974-82. PubMed ID: 18978956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR143 mutational analysis in two Italian families with X-linked ocular albinism.
    Micale L; Augello B; Fusco C; Turturo MG; Granatiero M; Piemontese MR; Zelante L; Cecconi A; Merla G
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):527-31. PubMed ID: 19604113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital nasal pyriform aperture stenosis and ocular albinism co-occurring in a sibship with a maternally-inherited 97 kb Xp22.2 microdeletion.
    Somsen D; Davis-Keppen L; Crotwell P; Flanagan J; Munson P; Stein Q
    Am J Med Genet A; 2014 May; 164A(5):1268-71. PubMed ID: 24478262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two novel mutations in families with X-linked ocular albinism.
    Iannaccone A; Gallaher KT; Buchholz J; Jennings BJ; Neitz M; Sidjanin DJ
    Mol Vis; 2007 Oct; 13():1856-61. PubMed ID: 17960122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats.
    Bassi MT; Ramesar RS; Caciotti B; Winship IM; De Grandi A; Riboni M; Townes PL; Beighton P; Ballabio A; Borsani G
    Am J Hum Genet; 1999 Jun; 64(6):1604-16. PubMed ID: 10330347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iris hyperpigmentation in a Chinese family with ocular albinism and the GPR143 mutation.
    Xiao X; Zhang Q
    Am J Med Genet A; 2009 Aug; 149A(8):1786-8. PubMed ID: 19610097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel splicing site mutation of the GPR143 gene in a Chinese X-linked ocular albinism pedigree.
    Cai CY; Zhu H; Shi W; Su L; Shi O; Cai CQ; Ling C; Li WD
    Genet Mol Res; 2013 Nov; 12(4):5673-9. PubMed ID: 24301936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal crossing of the optic fibres shown by evoked magnetic fields in patients with ocular albinism with a novel mutation in the OA1 gene.
    Lauronen L; Jalkanen R; Huttunen J; Carlsson E; Tuupanen S; Lindh S; Forsius H; Sankila EM; Alitalo T
    Br J Ophthalmol; 2005 Jul; 89(7):820-4. PubMed ID: 15965158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel
    Jung JH; Oh EH; Shin JH; Kim HS; Choi SY; Choi KD; Lee C; Choi JH
    J Genet; 2018 Dec; 97(5):1479-1484. PubMed ID: 30555098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel deletion in the OA1 gene: report of the first Spanish family with X-linked ocular albinism.
    Martinez-Garcia M; Riveiro-Alvarez R; Villaverde-Montero C; Cantalapiedra D; Garcia-Sandoval B; Ayuso C; Trujillo-Tiebas MJ
    Clin Exp Ophthalmol; 2010 Jul; 38(5):489-95. PubMed ID: 20649618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR143 mutations in Chinese patients with ocular albinism type 1.
    Jia X; Yuan J; Jia X; Ling S; Li S; Guo X
    Mol Med Rep; 2017 May; 15(5):3069-3075. PubMed ID: 28339057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel mutation in a Chinese family with X-linked ocular albinism.
    Wang Y; Guo X; Wei A; Zhu W; Li W; Lian S
    Eur J Ophthalmol; 2009; 19(1):124-8. PubMed ID: 19123159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterization of a family affected with X-linked ocular albinism (OA1).
    Lam BL; Fingert JH; Shutt BC; Singleton EM; Merin LM; Brown HH; Sheffield VC; Stone EM
    Ophthalmic Genet; 1997 Dec; 18(4):175-84. PubMed ID: 9457748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene.
    Oetting WS
    Hum Mutat; 2002 Feb; 19(2):85-92. PubMed ID: 11793467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the OA1 gene in ocular albinism.
    Camand O; Boutboul S; Arbogast L; Roche O; Sternberg C; Sutherland J; Levin A; Héon E; Menasche M; Dufier J; Abitbol M
    Ophthalmic Genet; 2003 Sep; 24(3):167-73. PubMed ID: 12868035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel GPR143 mutation in a Chinese family with X‑linked ocular albinism type 1.
    Gao X; Liu T; Cheng X; Dai A; Liu W; Li R; Zhang M
    Mol Med Rep; 2020 Jan; 21(1):240-248. PubMed ID: 31746431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic and clinical evaluation of three Chinese families with X-linked ocular albinism.
    Zou X; Li H; Yang L; Sun Z; Yuan Z; Li H; Sui R
    Sci Rep; 2017 Feb; 7():33713. PubMed ID: 28211458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OA1 mutations and deletions in X-linked ocular albinism.
    Schnur RE; Gao M; Wick PA; Keller M; Benke PJ; Edwards MJ; Grix AW; Hockey A; Jung JH; Kidd KK; Kistenmacher M; Levin AV; Lewis RA; Musarella MA; Nowakowski RW; Orlow SJ; Pagon RS; Pillers DA; Punnett HH; Quinn GE; Tezcan K; Wagstaff J; Weleber RG
    Am J Hum Genet; 1998 Apr; 62(4):800-9. PubMed ID: 9529334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular albinism type 1: more than meets the eye.
    Shen B; Samaraweera P; Rosenberg B; Orlow SJ
    Pigment Cell Res; 2001 Aug; 14(4):243-8. PubMed ID: 11549106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.